Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis
- PMID: 28739265
- PMCID: PMC5632589
- DOI: 10.1016/j.bbamcr.2017.07.011
Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis
Abstract
A disintegrin and metalloproteinases (ADAMs) are a family of mSultidomain, membrane-anchored proteases that regulate diverse cellular functions, including cell adhesion, migration, proteolysis and other cell signaling events. Catalytically-active ADAMs act as ectodomain sheddases that proteolytically cleave type I and type II transmembrane proteins and some GPI-anchored proteins from the cellular surface. ADAMs can also modulate other cellular signaling events through a process known as regulated intramembrane proteolysis (RIP). Through their proteolytic activity, ADAMs can rapidly modulate key cell signaling pathways in response to changes in the extracellular environment (e.g. inflammation) and play a central role in coordinating intercellular communication. Dysregulation of these processes through aberrant expression, or sustained ADAM activity, is linked to chronic inflammation, inflammation-associated cancer and tumorigenesis. ADAM10 was the first disintegrin-metalloproteinase demonstrated to have proteolytic activity and is the prototypic ADAM associated with RIP activity (e.g. sequential Notch receptor processing). ADAM10 is abundantly expressed throughout the gastrointestinal tract and during normal intestinal homeostasis ADAM10 regulates many cellular processes associated with intestinal development, cell fate specification and maintenance of intestinal stem cell/progenitor populations. In addition, several signaling pathways that undergo ectodomain shedding by ADAM10 (e.g. Notch, EGFR/ErbB, IL-6/sIL-6R) help control intestinal injury/regenerative responses and may drive intestinal inflammation and colon cancer initiation and progression. Here, I review some of the proposed functions of ADAM10 associated with intestinal crypt homeostasis and tumorigenesis within the gastrointestinal tract in vivo. This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiology edited by Stefan Rose-John.
Keywords: ADAM10; Cell lineage specification; Intestinal stem cells; Notch.
Copyright © 2017 Elsevier B.V. All rights reserved.
Figures


Similar articles
-
ADAM Proteases and Gastrointestinal Function.Annu Rev Physiol. 2016;78:243-76. doi: 10.1146/annurev-physiol-021014-071720. Epub 2015 Nov 19. Annu Rev Physiol. 2016. PMID: 26667078 Free PMC article. Review.
-
The plasma membrane: Penultimate regulator of ADAM sheddase function.Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2082-2087. doi: 10.1016/j.bbamcr.2017.06.006. Epub 2017 Jun 15. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28624437 Review.
-
Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17.Int J Mol Sci. 2021 Feb 12;22(4):1846. doi: 10.3390/ijms22041846. Int J Mol Sci. 2021. PMID: 33673337 Free PMC article.
-
The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).PLoS One. 2013 Aug 28;8(8):e73296. doi: 10.1371/journal.pone.0073296. eCollection 2013. PLoS One. 2013. PMID: 24015300 Free PMC article.
-
ADAM10 regulates Notch function in intestinal stem cells of mice.Gastroenterology. 2014 Oct;147(4):822-834.e13. doi: 10.1053/j.gastro.2014.07.003. Epub 2014 Jul 16. Gastroenterology. 2014. PMID: 25038433 Free PMC article.
Cited by
-
ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer Formation.Int J Mol Sci. 2020 Jul 20;21(14):5133. doi: 10.3390/ijms21145133. Int J Mol Sci. 2020. PMID: 32698506 Free PMC article. Review.
-
Potential impact of ADAM-10 genetic variants with the clinical features of oral squamous cell carcinoma.J Cell Mol Med. 2023 Apr;27(8):1144-1152. doi: 10.1111/jcmm.17728. Epub 2023 Mar 22. J Cell Mol Med. 2023. PMID: 36946281 Free PMC article.
-
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Med Sci (Basel). 2018 Apr 13;6(2):31. doi: 10.3390/medsci6020031. Med Sci (Basel). 2018. PMID: 29652830 Free PMC article. Review.
-
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.Int J Mol Sci. 2018 Feb 2;19(2):450. doi: 10.3390/ijms19020450. Int J Mol Sci. 2018. PMID: 29393911 Free PMC article. Review.
-
ADAM10 is a key player in the diagnosis, prognosis and metastasis of non-small cell lung cancer (NSCLC).J Cancer. 2025 Feb 11;16(5):1736-1746. doi: 10.7150/jca.107236. eCollection 2025. J Cancer. 2025. PMID: 39991567 Free PMC article.
References
-
- Howard L, Glynn P. Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation. Methods Enzymol. 1995;248:388–395. - PubMed
-
- Weber S, Saftig P. Ectodomain shedding and ADAMs in development. Development. 2012;139:3693–3709. - PubMed
-
- Endres K, Fahrenholz F. Regulation of alpha-secretase ADAM10 expression and activity. Exp Brain Res. 2012;217:343–352. - PubMed
-
- Reiss K, Saftig P. The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions. Seminars in cell & developmental biology. 2009;20:126–137. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous